ICH prepares for global quality implementation
The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a meeting of the steering committee and expert working groups last week.
The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a meeting of the steering committee and expert working groups last week.
Several annexes to
Also of interest to the pharmaceutical manufacturers, ICH’s Quality Implementation Working Group, which is focusing on the quality trio (Q8 Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System), set a schedule for training workshops in each of the three ICH regions. "This training will consist of case studies representing the four phases of the life cycle of a pharmaceutical product," according the ICH release. The workshops will be held in Brussels in June 2010, in Washington, DC, in October 2010, and in Tokyo in November 2010.
Other highlights of the meeting: ICH S9 Nonclinical Evaluation of Anticancer Pharmaceuticals reached Step 4 of the harmonization process. ICH S6 Revision of Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals reached Step 2. In addition, ICH safety experts held a day-long brainstorming session to discuss how to fill current gaps in safety guidelines.
The next ICH Steering Committee will be held in Europe in June 2010. The group meets twice every year.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

